Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
AU626404B2 - A controlled release formulation of 4-(2,1,3-benzoxadizaol-4 -yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridine dicarboxylate ester - Google Patents
[go: Go Back, main page]

AU626404B2 - A controlled release formulation of 4-(2,1,3-benzoxadizaol-4 -yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridine dicarboxylate ester - Google Patents

A controlled release formulation of 4-(2,1,3-benzoxadizaol-4 -yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridine dicarboxylate ester

Info

Publication number
AU626404B2
AU626404B2 AU53020/90A AU5302090A AU626404B2 AU 626404 B2 AU626404 B2 AU 626404B2 AU 53020/90 A AU53020/90 A AU 53020/90A AU 5302090 A AU5302090 A AU 5302090A AU 626404 B2 AU626404 B2 AU 626404B2
Authority
AU
Australia
Prior art keywords
benzoxadizaol
dihydro
dimethyl
controlled release
release formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU53020/90A
Other versions
AU5302090A (en
Inventor
Othmar Zuger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU5302090A publication Critical patent/AU5302090A/en
Application granted granted Critical
Publication of AU626404B2 publication Critical patent/AU626404B2/en
Assigned to NOVARTIS AG reassignment NOVARTIS AG Request to Amend Deed and Register Assignors: SANDOZ LTD.
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

AU53020/90A 1985-10-01 1990-04-09 A controlled release formulation of 4-(2,1,3-benzoxadizaol-4 -yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridine dicarboxylate ester Expired AU626404B2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB858524135A GB8524135D0 (en) 1985-10-01 1985-10-01 Darodipine compositions
GB8524135 1985-10-01
GB8524653 1985-10-07
GB8531419 1985-12-20
GB8503097 1986-02-07
GB8605037 1986-02-28

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU63226/86A Division AU598751B2 (en) 1985-02-07 1986-09-29 Pharmaceutical formulations with controlled release of the active substance

Publications (2)

Publication Number Publication Date
AU5302090A AU5302090A (en) 1990-08-09
AU626404B2 true AU626404B2 (en) 1992-07-30

Family

ID=10585981

Family Applications (1)

Application Number Title Priority Date Filing Date
AU53020/90A Expired AU626404B2 (en) 1985-10-01 1990-04-09 A controlled release formulation of 4-(2,1,3-benzoxadizaol-4 -yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridine dicarboxylate ester

Country Status (4)

Country Link
JP (1) JPS62149618A (en)
AU (1) AU626404B2 (en)
GB (1) GB8524135D0 (en)
ZA (1) ZA867507B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1956083A (en) * 1982-09-27 1984-04-05 Sandoz Ltd. Compositions containing benzoxadiazole - or benzthiadiazole - dihydropyridines

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
DE3045135A1 (en) * 1980-11-29 1982-06-09 Sandoz-Patent-GmbH, 7850 Lörrach BODEGRADABLE POLYMERS CONTAINING PHARMACEUTICAL COMPOSITIONS
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
JPS60202912A (en) * 1984-03-28 1985-10-14 Hitachi Metals Ltd Manufacture of anisotropic magnet roll

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1956083A (en) * 1982-09-27 1984-04-05 Sandoz Ltd. Compositions containing benzoxadiazole - or benzthiadiazole - dihydropyridines

Also Published As

Publication number Publication date
JPS62149618A (en) 1987-07-03
GB8524135D0 (en) 1985-11-06
AU5302090A (en) 1990-08-09
ZA867507B (en) 1988-05-25

Similar Documents

Publication Publication Date Title
AU6720087A (en) 4-(2-thiazolyl- and 4-(2-thiazolylamino-phenyl)-1,4- dihydropyridine derivatives
AU1828288A (en) Heterocyclic substituted piperidine or tetrahydropyridine compounds
AU1760988A (en) Enhancers for the transdermal flux of certain 1,4-dihydropyridine derivatives
AU570534B2 (en) Esters of 1,4-dihydro-2,6-dimethyl-pyridine-3,5- -dicarboxylic acid
AU5111485A (en) Trisubstituted piperidine derivatives
NZ219868A (en) Amlodipine salts (3 ethyl 5-methyl -2-(aminoethoxymethyl)- 4-(2-chlorophenyl)-1,4-dihydro-6-methylpyridine-3,5- dicarboxylate) and pharmaceutical compositions
AU587539B2 (en) Picolinic acid derivatives and herbicidal compositions
CA2106200A1 (en) Stereoselective preparation of substituted piperidines
IL103010A0 (en) Preparation of 4-substituted 1,4-dihydropyridines
AU7771187A (en) 1-acyl-2- aminomethyl piperidine derivatives
AU625968B2 (en) Piperidine derivatives
AU8286787A (en) Novel piperidine derivatives
AU7416087A (en) Antihypertensive dihydropyridine derivatives
IL84894A0 (en) Resolution of 1,4-dihydropyridine derivatives and optically active derivative salts of such derivatives
AU5222086A (en) Substituted dihydropyridine derivatives
AU626404B2 (en) A controlled release formulation of 4-(2,1,3-benzoxadizaol-4 -yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridine dicarboxylate ester
AU591093B2 (en) Antihypertensive dihydropyridine derivatives
AU566026B2 (en) Dihydropyridine anti-ischaemic and antihypertensive agents
NZ217732A (en) Controlled release formulation for oral administration which includes either pindolol or a 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridine dicarboxylate ester
AU6984987A (en) Substituted 1,4-dihydropyridine ester derivatives
IL89536A0 (en) Preparation of 1,4-dihydropyridine derivatives
AU5339486A (en) Dihydropyridine derivatives
AU5326186A (en) Dihydropyridine derivatives
AU5326386A (en) Antihypertensive dihydropyridine derivatives
AU1275188A (en) Pyridine and dihydropyridine 3,5 dicarboxylate derivatives